https://doi.org/10.1016/j.lungcan.2019.05.034
C
Changli Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
737
Citations
13
h-index
15
i10-index
Changli Wang is an academic researcher from Second Military Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Lung Cancer Treatments and Mutations & Cancer-related molecular mechanisms research. The author has an h-index of 13, co-authored 39 publications.
ORCID: 0000-0003-3508-2918Papers by this author
worksCirculating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer
2019 · Lung Cancer · 33 citations
Exogenous acetate attenuates inflammatory responses through HIF-1α-dependent glycolysis regulation in macrophage
2024 · Cellular and Molecular Life Sciences · 19 citations
https://doi.org/10.1007/s00018-024-05521-8
Publisher Correction: Acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination
2019 · Experimental & Molecular Medicine · 7 citations
https://doi.org/10.1038/s12276-019-0296-1
Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis
2025 · Cellular & Molecular Biology Letters · 7 citations
https://doi.org/10.1186/s11658-025-00784-w
A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel
2017 · ESMO Open · 3 citations
https://doi.org/10.1136/esmoopen-2017-000174
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat